Volume 2, Pages 59-65 (August 2018) High Risk Characteristics for Recurrent Cardiovascular Events among Patients with Obstructive Sleep Apnoea in the.

Slides:



Advertisements
Similar presentations
The INSIGHT study - Reliable blood pressure control and additional benefits for hypertensive patients Anthony M Heagerty Department of Medicine Manchester.
Advertisements

OBSTRUCTIVE SLEEP APNEA IN PATIENTS WITH CORONARY ATERY DISEASE OBSTRUCTIVE SLEEP APNEA IN PATIENTS WITH CORONARY ATERY DISEASE By Ahmad Younis Professor.
Aim To determine the effects of a Coversyl- based blood pressure lowering regimen on the risk of recurrent stroke among patients with a history of stroke.
European trial on reduction of cardiac events with perindopril in stable coronary artery disease Presented at European Society of Cardiology 2003 EUROPA.
Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: Safety and Efficacy of Low Blood Pressures Among.
Date of download: 6/21/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Low-Dose Aspirin for Primary Prevention of Cardiovascular.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Procedural Outcomes of Chronic Total Occlusion Percutaneous.
The Sleep Apnea cardioVascular Endpoints study (SAVE) R. Doug McEvoy Professor of Medicine, Adelaide Institute for Sleep Health Flinders University, AUSTRALIA.
Dr John Cox Diabetes in Primary Care Conference Cork
Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study  Dr Jack R W Brownrigg,
Volume 20, Issue 7, Pages (July 2017)
The SPRINT Research Group
Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Diabetes: A Meta-Analysis  Stavros Stavrakis, MD  The American Journal.
Copyright © 2011 American Medical Association. All rights reserved.
Copyright © 2009 American Medical Association. All rights reserved.
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies  The Emerging.
Volume 138, Issue 5, Pages (November 2010)
Copyright © 2007 American Medical Association. All rights reserved.
Heart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations Cardiology 2015;132: DOI: / Fig. 1. Semilogarithmic.
Copyright © 2012 American Medical Association. All rights reserved.
Tetsuro Tsujimoto, Hiroshi Kajio  International Journal of Cardiology 
Circ Cardiovasc Qual Outcomes
Hazard ratio (HR) for mortality for a 1-kg/m2 increase in body mass index (BMI) across the range of baseline BMI among patients with acute ischemic stroke.
Volume 14, Issue 6, Pages (June 2017)
SAVE Trial design: Patients with moderate to severe obstructive sleep apnea (OSA) and known CV disease were randomized in a 1:1 fashion to either CPAP.
Systolic Blood Pressure Intervention Trial (SPRINT)
Obstructive sleep apnea and risk of cardiovascular disease and all-cause mortality: A meta-analysis of prospective cohort studies  Xia Wang, Yingying.
Relationship Between Health-related Behavioral and Psychological Factors and Cardiovascular and Cerebrovascular Diseases Comorbidity Among Korean Adults.
Volume 11, Issue 9, Pages (September 2014)
The Hypertension in the Very Elderly Trial (HYVET)
Approach to the true resistant hypertensive and treatment approaches
Obstructive Sleep Apnea and Cardiovascular Disease
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies  The Emerging.
Volume 14, Issue 6, Pages (June 2017)
Body Composition and Heart Failure Prevalence and Prognosis: Getting to the Fat of the Matter in the “Obesity Paradox”  Carl J. Lavie, MD, Richard V.
Primacy of the 3B Approach to Control Risk Factors for Cardiovascular Disease in Type 2 Diabetes Patients  Linong Ji, MD, Dayi Hu, MD, Changyu Pan, MD,
Dileep Raman et al. JACEP 2017;3:
Syncope: Outcomes and Conditions Associated with Hospitalization
Diagnostic and management strategy recommended in obstructive sleep apnoea syndrome (OSAS) suspicion [52, 75–77]. Diagnostic and management strategy recommended.
Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies 
Influence of Diabetes Mellitus on Long-Term Clinical and Economic Outcomes After Coronary Artery Bypass Grafting  Heng Zhang, MD, Xin Yuan, MD, PhD, Ruben.
Coronary artery bypass grafting in diabetics: A growing health care cost crisis  Sajjad Raza, MD, Joseph F. Sabik, MD, Ponnuthurai Ainkaran, MS, Eugene.
Tetsuro Tsujimoto, Hiroshi Kajio  International Journal of Cardiology 
Blood Pressure and Outcomes in Very Old Hypertensive Coronary Artery Disease Patients: An INVEST Substudy  Scott J. Denardo, MD, Yan Gong, PhD, Wilmer.
Figure 1 Diagram showing analysis flow of patient selection and treatment allocation of ONTARGET/TRANSCEND. Figure 1 Diagram showing analysis flow of patient.
Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular disease  Johannes F.E. Mann, Qi-Long.
Volume 375, Issue 9725, Pages (May 2010)
Off-pump versus on-pump coronary artery bypass grafting: Insights from the Arterial Revascularization Trial  Umberto Benedetto, MD, PhD, Douglas G. Altman,
Volume 155, Issue 4, Pages (April 2019)
Long-Term Survival After Coronary Arterial Grafts in Patients With End-Stage Renal Disease  Taro Nakatsu, MD, Nobushige Tamura, MD, PhD, Yutaka Sakakibara,
Risks for Cardiovascular and Cardiac Deaths in Nonobese Patients With Diabetes and Coronary Heart Disease  Tetsuro Tsujimoto, MD, PhD, Hiroshi Kajio,
Pulse pressure for selecting the optimal cardiac strategy in patients with type 2 diabetes and coronary artery disease  Tetsuro Tsujimoto, Hiroshi Kajio 
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies  The Emerging.
Baseline Characteristics of the Subjects*
Volume 80, Issue 6, Pages (September 2011)
Volume 73, Issue 8, Pages (April 2008)
Volume 64, Issue 2, Pages (August 2003)
Clinical renoprotection trials involving angiotensin II-receptor antagonists and angiotensin-converting-enzyme inhibitors  Barry M. Brenner, Joann Zagrobelny 
An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61
Michael R. Lattanzio, Matthew R. Weir  Kidney International 
Diabetes, prediabetes, and cardiovascular risk: Shifting the paradigm
Volume 75, Issue 1, Pages (January 2009)
Associations between type of MI and incident HF
An ACCORD BP sub-analysis HR: 1.06; 95%CI: ; P=0.61
Additional benefit of PCSK9 inhibition in high risk patients after myocardial infarction A FOURIER subanalysis Primary endpoint: composite of CV death,
ROC curves for cardiovascular events, all-cause mortality, and disease progression. ROC curves for cardiovascular events, all-cause mortality, and disease.
Multivariable-adjusted HRs and 95% CIs for outcomes for waist circumference. Multivariable-adjusted HRs and 95% CIs for outcomes for waist circumference.
Subgroup analysis of associations between daily tea consumption and risk of ischaemic heart disease (IHD) according to potential baseline risk factors.
Magnus Dalén, MD, Torbjörn Ivert, MD, PhD, Martin J
Volume 14, Issue 6, Pages (June 2017)
Presentation transcript:

Volume 2, Pages 59-65 (August 2018) High Risk Characteristics for Recurrent Cardiovascular Events among Patients with Obstructive Sleep Apnoea in the SAVE Study  Weiwei Quan, Danni Zheng, R. Douglas McEvoy, Ferran Barbe, Riu Chen, Zhihong Liu, Kelly Loffler, Geraldo Lorenzi-Filho, Yuanming Luo, Sutapa Mukherjee, Manjari Tripathi, Richard Woodman, Qiang Li, Xia Wang, Hisatomi Arima, Yi Xiao, Xilong Zhang, Craig S. Anderson  EClinicalMedicine  Volume 2, Pages 59-65 (August 2018) DOI: 10.1016/j.eclinm.2018.09.002 Copyright © 2018 Terms and Conditions

Fig. 1 Conditional probabilities of indicator variables by OSA clinical phenotype. A. Coronary artery disease (CAD, dashed line) and CAD plus diabetes mellitus (CAD+DM, solid line) phenotype groups. B. Cerebrovascular disease (CeVD, dashed line) and CeVD plus diabetes mellitus (CeVD+DM, solid line) phenotype groups. Lines indicate the proportion of participants in each group identified with each feature shown on a concentric y axis. AHI indicates apnea hypopnea index, BMI body mass index, CAD coronary artery disease, DM diabetes mellitus, OSA obstructive sleep apnea, SBP systolic blood pressure, ST90 sleep time with oxygen saturation below 90%, ESS Epworth Sleepiness Scale. High AHI (≥30 events/h); high BMI (>30 kg/m2); high SBP (>140 mm Hg). EClinicalMedicine 2018 2, 59-65DOI: (10.1016/j.eclinm.2018.09.002) Copyright © 2018 Terms and Conditions

Fig. 2 Cumulative rate of cardiac and stroke outcomes by OSA clinical phenotype. (A) The primary endpoint was a composite of death from any CV cause, myocardial infarction, stroke, or hospitalisation for unstable angina, heart failure or, transient ischaemic attack. (B) Stroke events over time, according to phenotype group and adjusted for posterior probability. CAD coronary artery disease, CeVD cerebrovascular disease, CV cardiovascular, DM diabetes mellitus, OSA obstructive sleep apnoea. EClinicalMedicine 2018 2, 59-65DOI: (10.1016/j.eclinm.2018.09.002) Copyright © 2018 Terms and Conditions